Report Detail

Request for Sample of this report

Pharma & Healthcare Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Report 2021

  • RnM4300390
    • |
  • 16 June, 2021
    • |
  • Global
    • |
  • 143 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Live Vaccine
Inactivated Vaccine

Segment by Application
Government Tender
Marketing

The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is analysed and market size information is provided by regions (countries). Segment by Application, the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co., Ltd.
Tianjin Ruipu Biological Technology Co., Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co., Ltd.


1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview

  • 1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Scope
  • 1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
    • 1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Live Vaccine
    • 1.2.3 Inactivated Vaccine
  • 1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
    • 1.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Government Tender
    • 1.3.3 Marketing
  • 1.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Trends (2016-2027)

2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Forecasts by Region

  • 2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
    • 2.4.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)
    • 2.4.6 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Projections (2016-2027)

3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Competition Landscape by Players

  • 3.1 Global Top Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players by Sales (2016-2021)
  • 3.2 Global Top Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players by Revenue (2016-2021)
  • 3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2020)
  • 3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type

  • 4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2016-2021)
  • 4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Type (2022-2027)

5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application

  • 5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2016-2021)
  • 5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price Forecast by Application (2022-2027)

6 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures

  • 6.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
    • 6.1.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
    • 6.1.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
  • 6.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
    • 6.2.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
    • 6.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2022-2027)

7 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures

  • 7.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
    • 7.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
    • 7.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
  • 7.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
    • 7.2.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
    • 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures

  • 8.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
    • 8.1.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
    • 8.1.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
  • 8.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
    • 8.2.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
  • 8.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
    • 8.3.1 China 312 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures

  • 9.1 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
    • 9.1.1 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
    • 9.1.2 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
  • 9.2 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
    • 9.2.1 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures

  • 10.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
    • 10.1.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures

  • 11.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company
    • 11.1.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2016-2021)
    • 11.1.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2016-2021)
  • 11.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type
    • 11.2.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2022-2027)
  • 11.3 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application
    • 11.3.1 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Business

  • 12.1 CNADC
    • 12.1.1 CNADC Corporation Information
    • 12.1.2 CNADC Business Overview
    • 12.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.1.5 CNADC Recent Development
  • 12.2 Boehringer-Ingelheim
    • 12.2.1 Boehringer-Ingelheim Corporation Information
    • 12.2.2 Boehringer-Ingelheim Business Overview
    • 12.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.2.5 Boehringer-Ingelheim Recent Development
  • 12.3 MSD Animal Health
    • 12.3.1 MSD Animal Health Corporation Information
    • 12.3.2 MSD Animal Health Business Overview
    • 12.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.3.5 MSD Animal Health Recent Development
  • 12.4 Sinopharm
    • 12.4.1 Sinopharm Corporation Information
    • 12.4.2 Sinopharm Business Overview
    • 12.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.4.5 Sinopharm Recent Development
  • 12.5 Ceva
    • 12.5.1 Ceva Corporation Information
    • 12.5.2 Ceva Business Overview
    • 12.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.5.5 Ceva Recent Development
  • 12.6 Chengdu Tianbang Biological Products Co., Ltd.
    • 12.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
    • 12.6.2 Chengdu Tianbang Biological Products Co., Ltd. Business Overview
    • 12.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Development
  • 12.7 Tianjin Ruipu Biological Technology Co., Ltd.
    • 12.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
    • 12.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Business Overview
    • 12.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Development
  • 12.8 Qilu Animal Health
    • 12.8.1 Qilu Animal Health Corporation Information
    • 12.8.2 Qilu Animal Health Business Overview
    • 12.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.8.5 Qilu Animal Health Recent Development
  • 12.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
    • 12.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
    • 12.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview
    • 12.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development
  • 12.10 CAVAC
    • 12.10.1 CAVAC Corporation Information
    • 12.10.2 CAVAC Business Overview
    • 12.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.10.5 CAVAC Recent Development
  • 12.11 Komipharm
    • 12.11.1 Komipharm Corporation Information
    • 12.11.2 Komipharm Business Overview
    • 12.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.11.5 Komipharm Recent Development
  • 12.12 Agrovet
    • 12.12.1 Agrovet Corporation Information
    • 12.12.2 Agrovet Business Overview
    • 12.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.12.5 Agrovet Recent Development
  • 12.13 Bioveta
    • 12.13.1 Bioveta Corporation Information
    • 12.13.2 Bioveta Business Overview
    • 12.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.13.5 Bioveta Recent Development
  • 12.14 Jinyu Bio-Technology
    • 12.14.1 Jinyu Bio-Technology Corporation Information
    • 12.14.2 Jinyu Bio-Technology Business Overview
    • 12.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.14.5 Jinyu Bio-Technology Recent Development
  • 12.15 Phibro Animal Health
    • 12.15.1 Phibro Animal Health Corporation Information
    • 12.15.2 Phibro Animal Health Business Overview
    • 12.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.15.5 Phibro Animal Health Recent Development
  • 12.16 Tiankang
    • 12.16.1 Tiankang Corporation Information
    • 12.16.2 Tiankang Business Overview
    • 12.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.16.5 Tiankang Recent Development
  • 12.17 Zoetis
    • 12.17.1 Zoetis Corporation Information
    • 12.17.2 Zoetis Business Overview
    • 12.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.17.5 Zoetis Recent Development
  • 12.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
    • 12.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
    • 12.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview
    • 12.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development
  • 12.19 Plec Bioengineering Co., Ltd.
    • 12.19.1 Plec Bioengineering Co., Ltd. Corporation Information
    • 12.19.2 Plec Bioengineering Co., Ltd. Business Overview
    • 12.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
    • 12.19.5 Plec Bioengineering Co., Ltd. Recent Development

13 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis

  • 13.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
  • 13.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
  • 14.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers

15 Market Dynamics

  • 15.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
  • 15.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Drivers
  • 15.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
  • 15.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS). Industry analysis & Market Report on Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is a syndicated market report, published as Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,000.00
    		$6,000.00
    		$8,000.00
    		3,092.00
    		4,638.00
    		6,184.00
    		3,724.00
    		5,586.00
    		7,448.00
    		610,760.00
    		916,140.00
    		1,221,520.00
    		337,600.00
    		506,400.00
    		675,200.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo